Related Experiment Video
Updated: Jun 12, 2026
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
[Toxicologic characteristics of anti-tumor medication lisomustine]
Lisomustine, an anti-tumor drug, underwent toxicologic evaluation. Studies assessed acute toxicity, irritation, sensitization, mutagenicity, cumulative effects, and reproductive impacts to inform workplace safety regulations.
Area of Science:
- Toxicology
- Occupational Health
- Pharmacology
Background:
- Lisomustine is an anti-tumor medication requiring safety assessments.
- Understanding its toxicologic profile is crucial for occupational safety.
Purpose of the Study:
- To characterize the toxicologic properties of lisomustine.
- To provide data for hygienic regulation of workplace air concerning lisomustine exposure.
Main Methods:
- Experimental studies were conducted to evaluate toxicity.
- Assessed parameters included acute toxicity, irritative, resorptive, and sensitizing effects.
- Mutagenous, cumulative, and reproductive effects were also investigated.
Main Results:
- Data on acute toxicity were gathered.
- Irritative, resorptive, and sensitizing potentials were evaluated.
- Mutagenic, cumulative, and reproductive toxicity data were obtained.
Conclusions:
- The toxicologic characteristics of lisomustine were elucidated.
- Findings support the establishment of hygienic standards for occupational exposure to lisomustine.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
